ACTIVE

DRS. REMANS REUMATOLOGIE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result287,9 k €+14,2 %over 1 year
Gross margin463,5 k €+13,1 %over 1 year
Equity1,5 M €+19,7 %over 1 year

Identity

Source · BCE/KBO

DRS. REMANS REUMATOLOGIE is a Private limited company incorporated in 2010. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Genk.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0822.082.423
Incorporation
08/01/2010
Legal form
Private limited company
Registered office
Weg naar As 123
3600 Genk · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 330
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin463,5 k €410 k €374,6 k €349 k €334,9 k €
EBITDA434,7 k €379,1 k €333,3 k €198 k €184,6 k €
Operating result417,5 k €365,6 k €328,5 k €193,7 k €177,8 k €
Net result287,9 k €252,2 k €231,4 k €138,6 k €124,8 k €
Balance sheet
Equity1,5 M €1,2 M €960 k €1 M €875 k €
Total assets1,6 M €1,4 M €1,3 M €1,1 M €928,8 k €
Cash351,1 k €581,6 k €511,5 k €353,6 k €351,2 k €
Debts117 k €146,5 k €346,7 k €58,7 k €53,7 k €
Other
Workforce–0,5 ETP0,6 ETP1,5 ETP2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Philip Remans

Director

Active

Ended mandates

Philip REMANS

Director · since 31 mai 2022

Ended
Philip REMANS

Administrator - manager

Ended
Philip REMANS

Manager

Ended

Other companies at this address

Weg naar As 123 3600 Genk
CompanyCBE no.
Boelhouwers Reumatologie● Active
1000.932.310
GLOCOLEARNING● Active
0789.673.733
MAATSCHAP MARJAN● Active
0724.990.173
MEDISCH CENTRUM GENK● Active
0431.775.110
VERE● Active
0430.067.217

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/08/202630/07/202530/07/202425/07/202330/06/202230/06/2021
General meeting27/08/202630/06/202530/06/202430/06/202331/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202527/08/202631/08/2026DutchPDF
Abridged model31/12/202430/06/202530/07/2025DutchPDF
Abridged model31/12/202330/06/202430/07/2024DutchPDF
Abridged model31/12/202230/06/202325/07/2023DutchPDF
Abridged model31/12/202131/05/202230/06/2022DutchPDF
Abridged model31/12/202031/05/202130/06/2021DutchPDF
Abridged model31/12/201930/06/202008/07/2020DutchPDF
Abridged model31/12/201831/05/201921/06/2019DutchPDF
Abridged model31/12/201731/05/201828/06/2018DutchPDF
Abridged model31/12/201631/05/201729/06/2017DutchPDF
Abridged model31/12/201531/05/201629/06/2016DutchPDF
Abridged model31/12/201430/05/201527/07/2015DutchPDF
Abridged model31/12/201331/05/201428/07/2014DutchPDF
Abridged model31/12/201231/05/201326/08/2013DutchPDF
Abridged model31/12/201131/05/201230/08/2012DutchPDF
Abridged model31/12/201031/05/201111/07/2011DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Philip Remans

Director

Active

Ended mandates

Philip REMANS

Director · since 31 mai 2022

Ended
Philip REMANS

Administrator - manager

Ended
Philip REMANS

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/07/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/06/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/12/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other20/01/2010
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025287,9 k €↑
  2. 2024
    Annual accounts 2024252,2 k €↑
  3. 2023
    Annual accounts 2023231,4 k €↑
  4. 2022
    Annual accounts 2022138,6 k €↑
  5. 2021
    Annual accounts 2021124,8 k €↑
  6. 2020
    Annual accounts 2020115,8 k €↑
  7. 2019
    Annual accounts 201979,7 k €↑
  8. 2018
    Annual accounts 201850,8 k €↑
  9. 2017
    Annual accounts 201735,7 k €↓
  10. 2016
    Annual accounts 201654,7 k €↓
  11. 2015
    Annual accounts 201576 k €↓
  12. 2014
    Annual accounts 201477,2 k €↓
  13. 2013
    Annual accounts 2013128,5 k €↑
  14. 2012
    Annual accounts 201258,3 k €↓
  15. 2011
    Annual accounts 2011103,3 k €↑
  16. 2010
    Annual accounts 201076,9 k €
  17. 08/01/2010
    IncorporationPrivate limited company